Clinical evaluation of a new drug (1-phenyl-2-aminopropane alginate) for the treatment of obese patients in general practice.
D000464:Alginates; D000661:Amphetamine / Q000031:analogs & derivatives; D000662:Amphetamines; D058006:General Practice; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D009765:Obesity / Q000628:therapy*
D000464:Alginates; D000662:Amphetamines; D006603:Hexuronic Acids; D020723:Glucuronic Acid; D000661:Amphetamine
ALGINATES; AMPHETAMINE/related compounds; OBESITY/therapy